Actinium Pharmaceuticals SG&A Expense (Annual) Analysis

Actinium Pharmaceuticals Inc (ATNM)

7.21 +0.24 (+3.44%) USD | NYAM | Jul 08, 16:00

7.21 0.00 (0.00%) After-Hours: 18:56

SG&A Expense (Annual) Chart

Historical SG&A Expense (Annual) Data

View and export this data back to 2006. Upgrade now.

Date	Value
December 31, 2023	13.33M
December 31, 2022	12.00M
December 31, 2021	8.077M
December 31, 2020	6.308M
December 31, 2019	5.522M
December 31, 2018	6.732M
December 31, 2017	9.191M
December 31, 2016	9.019M
December 31, 2015	11.27M

Date	Value
December 31, 2014	10.18M
December 31, 2013	3.477M
December 31, 2012	4.506M
December 31, 2011	2.959M
December 31, 2010	0.0254M
December 31, 2009	0.0145M
December 31, 2008	0.0188M
December 31, 2007	0.0181M
December 31, 2006	0.0175M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Annual) Range, Past 5 Years

5.522M

Minimum

2019

13.33M

Maximum

2023

9.047M

Average

8.077M

Median

2021

SG&A Expense (Annual) Benchmarks